Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection
Publication Type:
Journal Article
Authors:
Afdhal, N.H.;
Stefan Zeuzem;
Kwo, P.Y.;
Chojkier, M.;
Gitlin, N.;
Puoti, M.;
Romero-Gomez, M.;
Zarski, J.P.;
Agarwal, K.;
Buggisch, P.;
Graham R. Foster;
Brau, N.;
Buti, M.;
Ira M. Jacobson;
Subramanian, G.M.;
Ding, X.;
Mo, H.;
Yang, J.C.;
Pang, P.S.;
Symonds, W.T.;
J G McHutchison;
Muir, A.J.;
Mangia, A.;
P. Marcellin;
ION-1 investigatorsSource:
N Engl J Med, Volume 370, Issue 20, p.1889-1898 (2014)
Keywords:
chronic HCV,
Fatigue,
Genotype,
genotype 1,
HCV,
Headache,
hepatitis,
Hepatitis C,
hepatitis C virus,
Infection,
methods,
Nausea,
NS5A inhibitor,
Patients,
Research,
Research Support,
Ribavirin,
sofosbuvir,
sustained virologic response,
therapy,
treatment
